Answers are grounded in this paper and cite their sources.
Chronological aging and acute/post-acute viral infections (such as SARS-CoV-2 Orf7b, Epstein-Barr Virus, Hepatitis C Virus, and Long COVID extracellular vesicles [LC-EVs]) have traditionally been investigated as distinct pathological entities. Here, we establish a unifying mechanistic framework demonstrating that aging and chronic viral persistence converge on a common master regulatory network. Specifically, aging-induced fidelity loss of p53 and SIRT6, combined with viral upregulation of c-Myc and RUNX2, dismantles protective non-coding RNA brakes (miR-145) and longevity deacetylase pathways. We uncover a key feed-forward mechanism wherein hyperactivated RUNX2 directly activates and stabilizes c-Myc [14, 15]. Elevated c-Myc subsequently represses miR-145 while upregulating Tissue Factor (TF) and thrombin via lncRNA MEG3 induction [16], accelerating arterial thrombosis and microvascular occlusion. This dual transcriptional and epigenetic assault disinhibits tissue-destructive proteases like Granzyme K (GzmK), paralyzes the NRF2-Parkin-PGC-1α mitochondrial/peroxisomal axis, and drives structural remodeling and functional decline across multiple organs. Using stiff ordinary differential equation (ODE) modeling, we demonstrate that targeted host-directed restoration via p53/NRF2 co-activation and SIRT6-dependent pathways successfully re-establishes homeostatic control, clearing pathological effectors and rejuvenating tissue function.
No takes yet. Share an insight, caveat, or question.
Boominathan Lakshmanane (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: